Suppr超能文献

正常眼压性青光眼发病机制与治疗的新认识。

New insights in the pathogenesis and treatment of normal tension glaucoma.

机构信息

University of Basel, Department of Ophthalmology, Basel, Switzerland.

出版信息

Curr Opin Pharmacol. 2013 Feb;13(1):43-9. doi: 10.1016/j.coph.2012.10.001. Epub 2012 Oct 22.

Abstract

Increased intraocular pressure (IOP) is a major risk factor for glaucomatous damage and reducing IOP improves prognosis. Nevertheless, there is little doubt that other risk factors besides IOP such as unstable ocular perfusion are involved. Blood flow is unstable if either the IOP fluctuates at a high level (or blood pressure fluctuates at a low level) or if the autoregulation of blood flow disturbed. A common cause for a disturbed OBF autoregulation is a primary vascular dysregulation (PVD) frequently observed in normal tension glaucoma patients. An unstable blood flow leads to recurrent mild reperfusion injury (chronic oxidative stress) affecting particularly the mitochondria of the optic nerve head. OBF regulation can be improved by magnesium, calcium channel blockers as well as with carbonic anhydrase inhibitors.

摘要

眼内压(IOP)升高是青光眼损害的主要危险因素,降低 IOP 可改善预后。然而,毫无疑问,除了 IOP 之外,其他危险因素如不稳定的眼灌注也参与其中。如果 IOP 波动较高(或血压波动较低),或者血流自动调节受到干扰,血流就会不稳定。血流自动调节紊乱的一个常见原因是原发性血管失调(PVD),这种情况在正常眼压青光眼患者中经常观察到。不稳定的血流导致反复出现的轻度再灌注损伤(慢性氧化应激),特别影响视神经头部的线粒体。通过镁、钙通道阻滞剂以及碳酸酐酶抑制剂可以改善眼血流调节。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验